HealthTech TAB

HealthTech TAB represents a European Commission-funded initiative that assembles distinguished healthtech industry professionals and entrepreneurs who possess extensive experience in advancing therapeutic solutions and medical devices through the complete development pipeline. This advisory board provides comprehensive support services including access to the Nanomedicine Translation Hub's characterization and pilot manufacturing capabilities, along with valuable networking opportunities for corporate partnerships and investor connections. As a fully subsidized service by the EC, participants retain complete ownership of their intellectual property without equity sacrifice or repayment obligations.

Building upon the impressive legacy of the nanomedTAB (Nanomedicine Translation Advisory Board), which successfully supported 84 projects and facilitated over €15 million in funding acquisition during just three years of operation, HealthTech TAB continues this tradition of excellence in healthtech acceleration. The program employs a sophisticated selection process to identify promising healthtech innovations across various development stages, from early research through clinical validation to market entry preparation. This selective approach ensures resources are directed toward projects with significant potential for healthcare impact and commercial viability.

What distinguishes HealthTech TAB's methodology is its holistic assessment framework that integrates technical feasibility, clinical relevance, regulatory pathway planning, and commercial potential evaluation within a single collaborative team environment. Unlike conventional accelerator programs that operate within rigid timeframes, this initiative offers flexible, milestone-based support that adapts to each project's unique development trajectory and challenges. This continuity of guidance represents a significant advantage for healthtech innovators navigating the complex path from concept to market adoption.

The program's pan-European scope enables access to diverse expertise across multiple healthcare systems, regulatory environments, and market dynamics throughout the continent. Participants benefit from specialized guidance in critical areas including regulatory strategy development, clinical trial design, manufacturing scale-up, reimbursement planning, and investment readiness preparation. By addressing both technical and commercial aspects of healthtech development simultaneously, HealthTech TAB significantly enhances participants' probability of successful translation while reducing development timelines and costs—ultimately accelerating the delivery of innovative healthcare solutions to patients across Europe and beyond.